Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity

Viral inclusion bodies (IBs) commonly form during the replication of Ebola virus (EBOV) in infected cells, but their role in viral immune evasion has rarely been explored. Here, we found that interferon regulatory factor 3 (IRF3), but not TANK-binding kinase 1 (TBK1) or IκB kinase epsilon (IKKε), wa...

Full description

Bibliographic Details
Main Authors: Lin Zhu, Jing Jin, Tingting Wang, Yong Hu, Hainan Liu, Ting Gao, Qincai Dong, Yanwen Jin, Ping Li, Zijing Liu, Yi Huang, Xuan Liu, Cheng Cao
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2024-01-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/88122
_version_ 1797339267794468864
author Lin Zhu
Jing Jin
Tingting Wang
Yong Hu
Hainan Liu
Ting Gao
Qincai Dong
Yanwen Jin
Ping Li
Zijing Liu
Yi Huang
Xuan Liu
Cheng Cao
author_facet Lin Zhu
Jing Jin
Tingting Wang
Yong Hu
Hainan Liu
Ting Gao
Qincai Dong
Yanwen Jin
Ping Li
Zijing Liu
Yi Huang
Xuan Liu
Cheng Cao
author_sort Lin Zhu
collection DOAJ
description Viral inclusion bodies (IBs) commonly form during the replication of Ebola virus (EBOV) in infected cells, but their role in viral immune evasion has rarely been explored. Here, we found that interferon regulatory factor 3 (IRF3), but not TANK-binding kinase 1 (TBK1) or IκB kinase epsilon (IKKε), was recruited and sequestered in viral IBs when the cells were infected by EBOV transcription- and replication-competent virus-like particles (trVLPs). Nucleoprotein/virion protein 35 (VP35)-induced IBs formation was critical for IRF3 recruitment and sequestration, probably through interaction with STING. Consequently, the association of TBK1 and IRF3, which plays a vital role in type I interferon (IFN-I) induction, was blocked by EBOV trVLPs infection. Additionally, IRF3 phosphorylation and nuclear translocation induced by Sendai virus or poly(I:C) stimulation were suppressed by EBOV trVLPs. Furthermore, downregulation of STING significantly attenuated VP35-induced IRF3 accumulation in IBs. Coexpression of the viral proteins by which IB-like structures formed was much more potent in antagonizing IFN-I than expression of the IFN-I antagonist VP35 alone. These results suggested a novel immune evasion mechanism by which EBOV evades host innate immunity.
first_indexed 2024-03-08T09:43:31Z
format Article
id doaj.art-3d9c0c2185cc4c8abbbfa832a8eb3d0e
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-03-08T09:43:31Z
publishDate 2024-01-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-3d9c0c2185cc4c8abbbfa832a8eb3d0e2024-01-29T16:29:40ZengeLife Sciences Publications LtdeLife2050-084X2024-01-011210.7554/eLife.88122Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunityLin Zhu0https://orcid.org/0000-0001-5772-9482Jing Jin1Tingting Wang2Yong Hu3Hainan Liu4Ting Gao5Qincai Dong6Yanwen Jin7Ping Li8Zijing Liu9Yi Huang10https://orcid.org/0000-0001-6585-5243Xuan Liu11Cheng Cao12Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaInstitute of Physical Science and Information Technology, Anhui University, Hefei, ChinaInstitute of Physical Science and Information Technology, Anhui University, Hefei, ChinaInstitute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaInstitute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaInstitute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaInstitute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaInstitute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaInstitute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaInstitute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaWuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, ChinaInstitute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaInstitute of Biotechnology, Academy of Military Medical Sciences, Beijing, ChinaViral inclusion bodies (IBs) commonly form during the replication of Ebola virus (EBOV) in infected cells, but their role in viral immune evasion has rarely been explored. Here, we found that interferon regulatory factor 3 (IRF3), but not TANK-binding kinase 1 (TBK1) or IκB kinase epsilon (IKKε), was recruited and sequestered in viral IBs when the cells were infected by EBOV transcription- and replication-competent virus-like particles (trVLPs). Nucleoprotein/virion protein 35 (VP35)-induced IBs formation was critical for IRF3 recruitment and sequestration, probably through interaction with STING. Consequently, the association of TBK1 and IRF3, which plays a vital role in type I interferon (IFN-I) induction, was blocked by EBOV trVLPs infection. Additionally, IRF3 phosphorylation and nuclear translocation induced by Sendai virus or poly(I:C) stimulation were suppressed by EBOV trVLPs. Furthermore, downregulation of STING significantly attenuated VP35-induced IRF3 accumulation in IBs. Coexpression of the viral proteins by which IB-like structures formed was much more potent in antagonizing IFN-I than expression of the IFN-I antagonist VP35 alone. These results suggested a novel immune evasion mechanism by which EBOV evades host innate immunity.https://elifesciences.org/articles/88122Ebola virusVP35VP24virus infectionvirus inclusion bodies
spellingShingle Lin Zhu
Jing Jin
Tingting Wang
Yong Hu
Hainan Liu
Ting Gao
Qincai Dong
Yanwen Jin
Ping Li
Zijing Liu
Yi Huang
Xuan Liu
Cheng Cao
Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
eLife
Ebola virus
VP35
VP24
virus infection
virus inclusion bodies
title Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
title_full Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
title_fullStr Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
title_full_unstemmed Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
title_short Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
title_sort ebola virus sequesters irf3 in viral inclusion bodies to evade host antiviral immunity
topic Ebola virus
VP35
VP24
virus infection
virus inclusion bodies
url https://elifesciences.org/articles/88122
work_keys_str_mv AT linzhu ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT jingjin ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT tingtingwang ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT yonghu ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT hainanliu ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT tinggao ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT qincaidong ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT yanwenjin ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT pingli ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT zijingliu ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT yihuang ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT xuanliu ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity
AT chengcao ebolavirussequestersirf3inviralinclusionbodiestoevadehostantiviralimmunity